SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-003349
Filing Date
2024-01-05
Accepted
2024-01-05 16:02:38
Documents
9
Effectiveness Date
2024-01-05

Document Format Files

Seq Description Document Type Size
1 S-8 d701282ds8.htm S-8 79468
2 EX-5.1 d701282dex51.htm EX-5.1 6541
3 EX-23.1 d701282dex231.htm EX-23.1 1417
4 EX-99.3(A) d701282dex993a.htm EX-99.3(A) 106881
5 EX-99.3(B) d701282dex993b.htm EX-99.3(B) 45657
6 EX-99.3(C) d701282dex993c.htm EX-99.3(C) 29342
7 EX-99.3(D) d701282dex993d.htm EX-99.3(D) 29894
8 EX-FILING FEES d701282dexfilingfees.htm EX-FILING FEES 22181
9 GRAPHIC g701282g0104043554292.jpg GRAPHIC 2723
  Complete submission text file 0001193125-24-003349.txt   326363
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276391 | Film No.: 24516185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)